COVID-19
| OPPORTUNITY NUMBER | OPPORTUNITY TITLE | AGENCY | POSTED DATE | CLOSE DATE |
|---|---|---|---|---|
| RFA-CE-24-013 | Research Grants to Identify Effective Community-Based Strategies for Overdose Prevention (R01) | HHS-CDC-HHSCDCERA | 08/30/2023 | 12/01/2023 |
| RFA-CE-24-030 | Research Grants for Preventing Violence and Violence Related Injury (R01) | HHS-CDC-HHSCDCERA | 08/30/2023 | 12/01/2023 |
| RFA-CE-24-012 | Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01) | HHS-CDC-HHSCDCERA | 08/30/2023 | 12/01/2023 |
| RFA-NS-24-025 | Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed) | HHS-NIH11 | 06/26/2023 | 11/08/2023 |
| PAR-23-214 | Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed) | HHS-NIH11 | 06/06/2023 | 10/04/2023 |
| RFA-NS-23-021 | Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional) | HHS-NIH11 | 03/28/2023 | 02/02/2024 |
| RFA-NS-23-022 | Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional) | HHS-NIH11 | 03/28/2023 | 02/02/2024 |
| RFA-OH-23-003 | Occupational Safety and Health Education and Research Centers (T42) | HHS-CDC-HHSCDCERA | 10/31/2022 | 11/23/2027 |